Mira Vision accelerates innovation at VENTURE SPRIN-D

We interviewed MIRA Vision founders, Lukas Mürdter and Leonid Mill, to gain insights into VENTURE SPRIN-D and what their start-up is all about. 

Cyber Valley: How has attending this event impacted Mira Vision? What were your key takeaways? 
 
Leonid Mill, MIRA Vision CTO & Founder, explains, “Attending the VENTURE SPRIN-D event was an outstanding experience for us. VENTURE SPRIN-D showcased the incredible innovation power of all the SPRIN-D portfolio start-ups, and it was truly inspiring to be part of such a dynamic environment. We deeply appreciated the opportunity to be part of this ecosystem and to participate and pitch on stage during the Superconnector session — it was a fantastic moment for us.” 

“The event provided an excellent platform to connect with like-minded entrepreneurs, industry experts, and investors. We had the pleasure of engaging in valuable conversations, receiving insightful feedback from investors, and exchanging ideas with other forward-thinking innovators.” 

“Overall, it was an exceptional opportunity that has positively impacted our journey, and we are grateful to have been part of it. Shoutout to SPRIN-D for this amazing event, creating such an inspiring platform that brings together so many bright minds and visionary thinkers – it’s initiatives like this that truly accelerate innovation,” Mill concludes.  

Cyber Valley: What is MIRA Vision? How is it already revolutionizing the health industry? 

CEO & Founder, Lukas Mürdter, explains: “MIRA Vision is a pioneering company in medical diagnostics. We use synthetic intelligence to analyze pathological images faster, more accurately, and at a fraction of the cost compared to traditional methods. By relying on fully parametric synthetic training data – not real patient data and without using generative models – we’re solving three of the biggest issues in medical AI: bias, privacy, and data scarcity.”  

Mürdter further clarifies, “Right now, we’re already outperforming state-of-the-art models in key areas with just a fraction of the resources that are normally needed to train such systems. This means not only better diagnostics but also global accessibility – even in regions with limited infrastructure.” 

Cyber Valley: Where do you see MIRA Vision being used in the future?  

Lukas emphasizes, “Our vision goes beyond pathology. We see MIRA Vision as the backbone of diagnostics across all image-based disciplines – radiology, dermatology, ophthalmology, even surgery. Wherever an image can be taken, MIRA will analyze it. Ultimately, we want to give every doctor on this planet an AI-powered assistant that helps detect diseases early, accurately, and affordably – no matter where they are.” 

Cyber Valley: What are your plans to make a positive impact on the world? 

Lukas responds enthusiastically, “By being radically different – and radically better. Instead of building another AI that requires millions of patient records and insane GPU farms, we’ve designed a lightweight, scalable system built on expert-guided synthetic data. Our platform works out of the box, is regulation-friendly, and can be used for free in non-commercial settings.” 

“We’re opening the platform to the global pathology community, offering unmatched accuracy, no data privacy concerns, and unbeatable economics. Once they start using it – they won’t want to stop. That’s how we scale. And yes – we’re just getting started,” Mürdter concludes.